Immunic | VTL - Ordinary Share Capital


Immunic reported $120.38M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Alterity Therapeutics Limited AUD 10.88B 10.66B Dec/2025
BioMarin Pharmaceutical USD 193.27M 969K Mar/2026
Cipla INR 807.78M 17K Mar/2026
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 94.55M 1.02M Dec/2025
CSL USD 482.13M 93.87M Dec/2025
Enanta Pharmaceuticals USD 212K 1000 Dec/2023
Grifols EUR 680.58M 846.11K Dec/2025
Immunic USD 120.38M 21.73M Dec/2025
Insmed USD 216.52M 2.27M Mar/2026
Omeros USD 611K 17K Dec/2023
OraSure Technologies USD 70.39M 1.87M Dec/2025
Quidel USD 67.9M 0 Dec/2025
Ultragenyx Pharmaceutical USD 98.3M 1.7M Mar/2026
United Therapeutics USD 42.16M 1.49M Mar/2026
Xoma USD 87K 1000 Jun/2024